Lon Sbtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lon sbtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lon Sbtx Today - Breaking & Trending Today
SkinBioTherapeutics plc (LON:SBTX – Get Free Report) shares hit a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 10.76 ($0.14) and last traded at GBX 11.20 ($0.14), with a volume of 3135234 shares trading hands. The stock had previously closed at GBX 12.75 ($0.16). SkinBioTherapeutics Price Performance […] ....
SkinBioTherapeutics Plc (LON:SBTX – Get Free Report) shares were down 2.4% during mid-day trading on Monday . The company traded as low as GBX 19.04 ($0.24) and last traded at GBX 20 ($0.25). Approximately 442,793 shares were traded during mid-day trading, an increase of 6% from the average daily volume of 418,282 shares. The stock […] ....
SkinBioTherapeutics Plc (LON:SBTX – Get Free Report)’s share price dropped 3.4% on Monday . The stock traded as low as GBX 21.04 ($0.26) and last traded at GBX 21.50 ($0.26). Approximately 260,935 shares were traded during trading, a decline of 36% from the average daily volume of 409,569 shares. The stock had previously closed at […] ....
SkinBioTherapeutics Plc (LON:SBTX – Get Free Report) shares reached a new 52-week low during trading on Friday . The stock traded as low as GBX 11 ($0.14) and last traded at GBX 11.80 ($0.15), with a volume of 142093 shares traded. The stock had previously closed at GBX 12.13 ($0.16). SkinBioTherapeutics Stock Performance The stock […] ....
26 May 2021 | 09:14am StockMarketWire.com - Skin health focused SkinBioTherapeutics said a study of consumers using one of its food supplements had garnered highly positive feedback. The AxisBiotix-Ps powered supplement was designed to modulate the immune system by harnessing the gut-skin axis, to address problems associated with sensitive skin conditions such as psoriasis. A 56-day self-managed consumer study commenced in February with 76% of participants that self-identified as suffering from psoriasis reporting that their skin felt less itchy. Additionally, 75% reported that their skin appeared less red, 73% reported that their skin felt less irritable and 65% reported that they had fewer flaky patches of skin. ....